What is the recommended antibiotic regimen for urethritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The recommended antibiotic regimen for urethritis is doxycycline 100mg twice daily for 7 days or azithromycin 1g as a single oral dose, depending on whether the urethritis is gonococcal or non-gonococcal. For gonococcal urethritis, the first-line treatment is a single 1g intramuscular or intravenous dose of ceftriaxone 1. For non-gonococcal urethritis, doxycycline is preferred due to emerging resistance concerns, but azithromycin can be used as an alternative 1.

Key Considerations

  • Patients should abstain from sexual activity for 7 days after treatment initiation and until symptoms resolve.
  • Partners from the previous 60 days should be notified and treated to prevent reinfection.
  • Treatment failure may occur due to antimicrobial resistance, non-adherence, or reinfection, so follow-up testing is recommended if symptoms persist.

Antibiotic Options

  • Doxycycline 100mg twice daily for 7 days
  • Azithromycin 1g as a single oral dose
  • Ceftriaxone 1g intramuscular or intravenous dose for gonococcal urethritis

Evidence

The European Association of Urology guidelines on urological infections provide the most recent and highest quality evidence for the treatment of urethritis 1. These guidelines recommend doxycycline and azithromycin as first-line treatments for non-gonococcal urethritis, and ceftriaxone as the first-line treatment for gonococcal urethritis. The Centers for Disease Control and Prevention also provide guidelines for the treatment of urethritis, but the European Association of Urology guidelines are more recent and of higher quality 1.

From the FDA Drug Label

Uncomplicated urethral, endocervical, or rectal infection in adults caused by Chlamydia trachomatis: 100 mg, by mouth, twice a day for 7 days. Nongonococcal urethritis (NGU) caused by C. trachomatis or U. urealyticum: 100 mg, by mouth, twice a day for 7 days. Gonococcal urethritis and cervicitisOne single 2 gram dose

The recommended antibiotic regimen for urethritis is:

  • Doxycycline: 100 mg, by mouth, twice a day for 7 days for uncomplicated urethral, endocervical, or rectal infection in adults caused by Chlamydia trachomatis and for nongonococcal urethritis (NGU) caused by C. trachomatis or U. urealyticum 2
  • Azithromycin: One single 2 gram dose for gonococcal urethritis and cervicitis 3 Key points:
  • The choice of antibiotic depends on the cause of the urethritis.
  • Doxycycline and azithromycin are both effective options for the treatment of urethritis.
  • The dosage and duration of treatment may vary depending on the specific diagnosis and the patient's medical history.

From the Research

Urethritis Antibiotic Regimen

The recommended antibiotic regimen for urethritis depends on the cause of the infection. The most common causes of urethritis are Chlamydia trachomatis and Neisseria gonorrhoeae.

Treatment Options

  • For gonococcal urethritis, a single 500 mg intramuscular dose of ceftriaxone is recommended, along with concurrent treatment with doxycycline (100 mg orally twice a day for 7 days) if chlamydial infection has not been excluded 4.
  • For nongonococcal urethritis, a single oral dose of azithromycin (1-2 g) or a 7-day course of doxycycline (100 mg orally twice a day) may be effective 5, 6, 7, 8.
  • Azithromycin has been shown to be as effective as doxycycline in achieving clinical cure in patients with nongonococcal urethritis, with the advantage of a single dose or shorter treatment course 6, 7.

Considerations

  • The choice of antibiotic regimen should be based on the patient's symptoms, medical history, and laboratory test results.
  • Patients with persistent or recurrent symptoms require careful re-evaluation and retreatment with antimicrobial agents if necessary 5.
  • The emergence of antimicrobial resistance is a concern, and treatment failures should be reported to ensure the continued efficacy of recommended regimens 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.